29 May Liraglutide Lowers Cardiovascular Outcomes in Type 2 Diabetes
Posted at 00:00h
in Clinical Trials
New England Journal of Medicine
Diabetes research shows Liraglutide lowers Cardiovascular outcomes in Type 2 Diabetes, per The New England Journal of Medicine.